Updated Oct 13, 12:37 PM ET
Petition filed
Plan confirmed
Clearside Biomedical’s plan became effective on July 14, 2026, with Steel Partners operating the reorganized debtor and a Plan Administrator appointed, according to the July operating report Dkt. 494. The October 2, 2026 final fee order Dkt. 508 approved professionals’ compensation and directed payment of remaining unpaid fees and expenses, making those payments the next expressly ordered step.
Search available documents for this case. Full docket access requires Pro.
Open case researchClearside Biomedical: Equity Holders Challenge $2.7M Stalking Horse in Debt-Free Bankruptcy ·
Case facts and filing dates come from court records.